Pricing Log in Create free account

Delcath Systems, Inc. (DCTH) vs Sight Sciences, Inc. (SGHT)

Delcath Systems, Inc. and Sight Sciences, Inc. are both Medical Devices companies. Delcath Systems, Inc. and Sight Sciences, Inc. are of similar size ($513.9M and $484.8M). Sight Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Delcath Systems, Inc. trades at 1,408×. Delcath Systems, Inc. grew revenue faster over the last twelve months: 35.9% against 9.27%. Delcath Systems, Inc. has the higher net margin (0.56% vs −35.7%) and the higher return on invested capital (−4.49% vs −125.2%). Across the 18 metrics below, Delcath Systems, Inc. leads on 16 and Sight Sciences, Inc. on 2.

Valuation

Metric DCTH SGHT Medical Devices median
P/E 1,408.00 n/m 23.22
P/S 5.30 5.41 2.34
P/B 4.17 8.53 2.33
Price to free cash flow 28.87 n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 4.31 4.95 2.24
Earnings yield 0.07% (6.76%) (10.09%)
Free cash flow yield 3.46% (5.17%) (8.47%)

Profitability

Metric DCTH SGHT Medical Devices median
Gross margin 87.05% 87.96% 56.01%
Operating margin (1.90%) (33.43%) (15.03%)
Net margin 0.56% (35.69%) (20.40%)
Free cash flow margin 18.35% (27.98%) (7.24%)
Return on equity 0.47% (48.42%) (15.32%)
Return on assets 0.42% (26.24%) (19.72%)
Return on invested capital (4.49%) (125.18%) (10.33%)

Growth

Metric DCTH SGHT Medical Devices median
Revenue growth (TTM) 35.85% 9.27% 8.80%
EPS growth (last fiscal year) 107.53% 28.16% 29.03%
Revenue growth, 5-year CAGR 120.21% 22.86% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DCTH SGHT Medical Devices median
Debt to equity 0.00 0.77 0.07
Current ratio 9.83 4.95 2.50
Net debt to EBITDA 132.51 1.45 0.49

Dividend

Metric DCTH SGHT Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric DCTH SGHT Medical Devices median
Market cap 513.89m 484.78m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack